Location History:
- Brooklyn, NY (US) (2022)
- New York, NY (US) (2023)
Company Filing History:
Years Active: 2022-2023
Title: Davide F Robbiani: Innovator in Antibody Research
Introduction
Davide F Robbiani is a prominent inventor based in New York, NY (US). He has made significant contributions to the field of immunology, particularly in the development of neutralizing antibodies against viral infections. With a total of 2 patents to his name, Robbiani's work is at the forefront of therapeutic strategies for combating viral diseases.
Latest Patents
Robbiani's latest patents include groundbreaking research on neutralizing anti-SARS-CoV-2 antibodies and methods of use thereof. This disclosure provides novel broadly neutralizing anti-SARS-CoV-2 antibodies or antigen-binding fragments thereof. The disclosed anti-SARS-CoV-2 antibodies constitute a novel therapeutic strategy in protection from SARS-CoV-2 infections. Another significant patent focuses on neutralizing antibodies that bind to the Zika virus domain III envelope region. This patent provides antibodies to Zika virus (ZIKV) and dengue 1 virus (DENV1), with methods for prophylaxis and therapy by administering the antibodies and combinations thereof. Immunological detection methods using the antibodies are also provided, along with vaccine compositions that comprise peptides derived from ZIKV and DENV1.
Career Highlights
Robbiani is affiliated with The Rockefeller University, where he conducts his research. His work has been instrumental in advancing the understanding of antibody responses to viral infections. His innovative approaches have garnered attention in the scientific community and have the potential to lead to significant advancements in therapeutic interventions.
Collaborations
One of his notable collaborators is Michel Nussenzweig, with whom he has worked on various research projects. Their combined expertise has contributed to the development of novel therapeutic strategies in immunology.
Conclusion
Davide F Robbiani is a key figure in the field of antibody research, with a focus on developing innovative solutions for viral infections. His contributions through patents and collaborations highlight the importance of ongoing research in this critical area of health.